The Forbidden Knowledge Business

How cholesterol influencers turn uncertainty into authority

Let me describe a business model.

You identify a group of people who are anxious about something - in this case, their very high cholesterol numbers.

You tell them their doctors are missing something important. You hype preliminary findings that are reassuring to them. You hype preliminary findings that are scary about the medications their doctors recommend. You frame all of this as brave truth-telling against an entrenched establishment that’s either too stupid or too financially conflicted to give it to them straight. You put the good stuff behind a paywall.¹ And crucially, you never have to sit across from any of these people if they have the heart attack.

This is what is happening in the cholesterol influencer space.

Patients are caught in the middle - regular people who have no interest in reading a scientific paper, who are trying to figure out how to protect themselves, and who certainly do not want to have a heart attack.

These are real people who are genuinely drowning in deliberately confusing information.

And too often those regular people aren’t being well served by the online conversations happening around them.

I’ve had a few patients come in recently asking me about the work of Nick Norwitz MD PhD, particularly his recent post about how his incredibly high LDL for 7 years didn’t result in any plaque on a CT scan.

Those conversations with patients inspired me to look into Norwitz’s work in more detail.

Reading his content was genuinely disappointing. He’s clearly a smart guy who is asking interesting questions and making useful observations that should promote a meaningful discussion.

But instead of pursuing the important question he’s implying - are there specific factors that protect some people’s arteries from very high LDL levels and how can we identify those factors in advance? - he spends his considerable intellectual firepower suggesting to people that their doctors are either too captured or too ignorant to give patients the real story.

The version of this conversation that would be genuinely useful

Norwitz followed a diet that led to his own cholesterol numbers looking remarkably elevated - an LDL around 500mg/dL for 7 years! - and obtained a coronary CTA² of his own heart arteries that showed no development of plaque after 7 years of what most people would consider dangerous LDL exposure.

This is a fascinating data point that provokes a ton of really interesting questions.

• Are we sure that the 7 years of exposure is enough time for the development of plaque?

• Is the CTA high enough resolution to see the fatty streaks in arteries that are a plaque precursor or to detect very small amounts of plaque?

• Do the rest of his arteries look as pristine as the arteries around his heart?

• Does he have some other protective factor that renders his high LDL meaningless - and if he does, how can other patients learn whether they share it?

In medicine, we learn a lot from biological outliers.

Much of the conventional wisdom on LDL cholesterol comes from these outliers - people who have very high levels from birth have a high risk of heart disease, but people who have low levels from birth have a very low risk of heart disease.

Outliers are how hypotheses get generated and refined.

A serious researcher would frame a finding like this with fascination and appropriate hedging. An acknowledgment that we need more data before widely applying this diet to the general population. A recognition that the body of evidence suggests that LDL is a risk factor for heart disease and that the burden of proof should lie with those who claim a particular context is different. An honest engagement with the unanswered question of whether diet induced LDL elevation is truly distinct from genetically high LDL or LDL elevation in a patient with metabolic syndrome.

That is not the framing that Norwitz has chosen.

---

The secret knowledge template

The explicit brand is curiosity, humility, care for complexity. The actual product is something different.

Look at what the content promises:

• “Give your doctor a heart attack”

• “A bet against cardiology”

• “Is science, and by extension medicine, captured?”

• “What if lowering cholesterol increased your risk of death?”

• “The statin study that should have changed medicine but no one is talking about it”

Those are not the titles of someone who believes in nuance. They are the titles of someone who has built an audience by making them feel they have access to forbidden knowledge - and who understands that the more contemptible their doctor seems, the more valuable that access appears. The concession that LDL matters is in the fine print. The message is in the headline.

The pattern across the content is consistent. A real but preliminary finding gets treated as a bombshell. Statins reduce GLP-1 levels - a genuine mechanistic finding from a real journal. A coronary CTA showing no plaque after seven years of sky high LDL elevation. A study showing that within a group of patients with uniformly sky-high LDL, absolute LDL level didn’t predict whose plaque progressed more.

Each gets the same treatment: why isn’t anyone talking about this? Why don’t doctors know? This should have been headline news!

The implied conclusion is that your doctor is either too stupid or too compromised, and that the person telling you this has figured out what medicine has missed.

The conclusion is never stated precisely like that, but it doesn’t need to be. The audience draws that conclusion themselves. And then they go home and wonder whether to refill their statin prescription.

The repeated move is treating mechanistic findings as if they were outcome data. The statin/GLP-1 paper tells you that statins reduce GLP-1 levels. It tells you nothing about whether that reduction produces worse cardiovascular outcomes net of the LDL benefit - which is the only question that matters clinically. Mechanism is not outcome.³

Promoting a mechanistic signal as suppressed knowledge your doctor isn’t telling you about exploits a gap that most lay readers don’t know exists.

Look at the video here, titled: “I Gave My Cardiologist a Heart Attack”

---

Why people want this to be true

It's worth acknowledging the emotional reality of the people this content is aimed at, because a critique that ignores it will always be easier to dismiss.

Low carb diets really help some people - some people feel better, lose weight, reverse type 2 diabetes. Some people feel better than they have in years - more energy, less inflammation, better metabolic numbers across the board. They adopt this way of eating for real reasons and experience real benefits.

And then they get a cholesterol number that terrifies them.

Their LDL is 280. Their doctor wants them on medications. They’re being told that the first thing in years that made them feel truly well is quietly killing them.

The cognitive dissonance can be profound and the anxiety is real.

Into that gap steps a content ecosystem that tells them: your doctor doesn’t understand your situation. The research your doctor is relying on doesn’t apply to you. There are people who have figured this out.

That is a genuinely powerful offer - of resolution, of vindication, of belonging to a group that knows something that the establishment doesn’t.

Norwitz agrees that LDL is a risk factor

To be precise about what I’m arguing: when you read his actual writing or listen to his videos carefully, Norwitz repeatedly acknowledges the role of LDL in the development of heart disease.

I don’t want to argue with a strawman by misrepresenting his claims.

But notice that the “aha” moment in his content is always a reason to be more skeptical of LDL as a risk factor worth modifying, or a reason for concern about the medical treatments designed to lower it. The acknowledgment that LDL matters lives in the body of the text.

The message that your doctor is missing something - that the statin study “no one is talking about” should have changed medicine, that watching a video will give your cardiologist a heart attack - lives in the headline, the title, the social media post, the thing that actually reaches people.

The concession is in the fine print. The message is in the billboard.

The KETO-CTA study doesn’t absolve LDL

I’ve written before about the KETO-CTA study and won’t rehash the full argument here.

But two major points are worth stating.

The first is that the central finding of the study - within this group of patients with very high LDL, the absolute LDL level didn’t predict changes in plaque over a year but the level of baseline plaque did - is basically a rehash of the finding of every single observational study ever done: sicker patients are sicker.

The second point is that not every patient who reads this information is a lean, metabolically healthy person in their early 30s with clean arteries and no alarming family history.

A lot of people have many more years of cumulative exposure to cardiovascular risk. They have high blood pressure. They have prediabetes. They don’t exercise regularly. They have a more concerning family history. Or they already have plaque in their arteries when they get introduced to the cholesterol-skeptic content.

Even if you take the central conclusion of the KETO-CTA study as true (which I have doubts about, but let’s play the steelman for a minute), then a low carb diet that raises LDL levels considerably is a really risky diet for a patient who already has plaque in their arteries.

Does every patient who adopts a low carb diet get a full scan of their blood vessels first?

No.

Does every patient draw a distinction between themselves and the 34 year old athlete who has never had hypertension or metabolic syndrome?

In my clinic, that context is generally absent.

There is also a structural conflict worth noting: Norwitz is simultaneously the subject of his own case report, an author on related studies, and the operator of a paid newsletter whose subscribers are specifically invested in the conclusion that high LDL may be safe. That constellation doesn’t prove distortion, but it is the kind of conflict that should be made visible.

Then you have to remember the KETO-CTA retraction request.

Norwitz framed this as scientific integrity - and disclosing analytical problems with third-party data does take something. But in the same announcement, he was emphatic that the core finding “remains incredibly robust” and “has not changed.” The retraction is requested on a technicality. The conclusion that built the brand is preserved. If data problems were serious enough to request retraction, intellectual honesty requires increasing uncertainty about all conclusions that depended on that data. That step doesn’t appear. What appears is a news cycle about his integrity, followed by continued assertion that the main finding stands.

---

None of the influencers have any accountability

Here is what distinguishes this enterprise from how medicine actually works: accountability.

If a physician tells a patient that their LDL of 290 is probably fine given their metabolic profile, that physician takes responsibility for what happens next.

If that person has a heart attack, the doctor is going to hear about it and has to answer to the patient and their family.

The feedback loop is real and personal. It shapes how you communicate uncertainty.

It shapes how confidently you say things to people who are frightened and looking for guidance.

Content creators have a completely different feedback loop because they optimize for paid subscribers, likes, shares, and comments.

The person who stops their statin after watching a video about GLP-1 depletion does not come back to report the outcome. The person who decides their LDL of 300 is fine because they’re lean and metabolically healthy does not appear in anyone’s analytics if they have an MI at 52.

The asymmetry between speaking and consequence is total. You can say things to hundreds of thousands of people that no physician would say to a single patient, because you will never have to take responsibility for what happens to those people afterward.

The patients I see are not all lean athletes with pristine triglycerides who adopted a well-formulated ketogenic diet. They are people with complicated histories, multiple risk factors, imperfect adherence, family histories they half-remember, and cholesterol numbers that scare them.

This framework offers patients a template for dismissing their risk that was never designed to apply to their situation. But the content isn’t always careful enough to tell them that.

---

The nuance claim

The explicit brand that he claims is nuance: staying curious, appreciating complexity, refusing to oversimplify.

The content systematically contradicts this.

Genuine nuance in cardiovascular medicine sounds like this: we have strong evidence across multiple different lines of study - genetics, observational studies, randomized controlled trials - that higher levels of LDL (or apoB, or non-HDL) raises risk of heart disease.

But LDL is not the only thing that drives the risk of heart disease. Blood pressure, diabetes, chronic inflammation, kidney disease, Lp(a), family history, and metabolic syndrome also play a role.

No serious doctor thinks that this is all just about LDL.

We have true uncertainty about what protective factors exist that protect some people some incredibly high LDL from heart attacks.

After all, in the familial hypercholesterolemia (FH) population, there is a 50% chance of a heart attack by age 50.

That means that half the people with incredibly high LDL don’t have heart attacks over a 50 year time horizon!

And we don’t really understand why that is. But some people with FH have heart attacks when they are incredibly young. There are tragic stories of kids losing parents at very early ages because of untreated high cholesterol numbers.

The interesting scientific question is not whether Norwitz's arteries are clean. It's what combination of factors might be protecting him, and how a serious research program would go about identifying those factors in people who don't already know they're outliers. That is the conversation worth having.

A nuanced conversation is not the conversation that Nick Norwitz has with his audience. Telling your audience that watching your video will give their cardiologist a heart attack is not nuance. Promoting a mechanistic GLP-1 finding as suppressed bombshell knowledge is not nuance. Amplifying a study’s most favorable subgroup result while the alarming headline finding goes unmentioned is not nuance. Requesting a retraction while insisting the main conclusion stands is not nuance.

The performance of scientific humility is not the same as scientific humility.

What is being produced is a selective campaign against confidence in LDL management, aimed at an audience that is motivated to believe their cholesterol numbers don’t matter, with the most actionable guidance behind a subscription fee.

The uncertainty is real. The selectivity of how that uncertainty gets deployed is a distortion.

The patients paying for this forbidden knowledge deserve better. And so do the patients who aren’t paying for it but are absorbing it anyway.

Those are the people sitting in clinics across the country, asking their doctors about something they read online, wondering whether the person who told them their statin is secretly working against them might be right.

Those patients are real. The heart attacks some of them will have are real.

The problem is not curiosity. The problem is selectively deploying curiosity in ways that almost always push frightened people toward reassurance and away from treatment.

Medicine is full of uncertainty. Patients deserve honest conversations about that uncertainty.

But uncertainty is not a license to selectively amplify evidence in ways that reassure frightened people while minimizing the possibility that the reassuring story might be wrong.

If you are going to tell hundreds of thousands of people that the medical establishment is missing something fundamental about LDL, you should bear some responsibility for what happens if they believe you.

Content that nudges them toward a specific decision and then disappears from accountability is not a contribution to public health. It is a product. And the people consuming it deserve to know the difference.

1. Maybe you even promise them that they’ll never get Alzheimer’s, but only if they just follow your paywalled protocol to prevent it.

2. A CT scan of the arteries of the heart optimized to see plaque

3. Mechanisms are still important and I am not dismissing them. We can develop treatments because we understand mechanisms. We can define biomarkers because we understand mechanisms. But mechanisms are generally incomplete models of how the human body works, and so when outcomes are different than mechanisms would suggest, it usually means either the mechanism doesn’t tell the whole story or the intervention has other off-target effects.